Altered Expression of Astrocyte-Related Receptors and Channels Correlates With Epileptogenesis in Hippocampal Sclerosis.


Journal

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
ISSN: 1615-5742
Titre abrégé: Pediatr Dev Pathol
Pays: United States
ID NLM: 9809673

Informations de publication

Date de publication:
Historique:
pubmed: 6 6 2019
medline: 28 4 2020
entrez: 6 6 2019
Statut: ppublish

Résumé

Hippocampal sclerosis (HS) is one of the major causes of intractable epilepsy. Astrogliosis in epileptic brain is a peculiar condition showing epileptogenesis and is thought to be different from the other pathological conditions. The aim of this study is to investigate the altered expression of astrocytic receptors, which contribute to neurotransmission in the synapse, and channels in HS lesions. We performed immunohistochemical and immunoblotting analyses of the P2RY1, P2RY2, P2RY4, Kir4.1, Kv4.2, mGluR1, and mGluR5 receptors and channels with the brain samples of 20 HS patients and 4 controls and evaluated the ratio of immunopositive cells and those expression levels. The ratio of each immunopositive cell per glial fibrillary acidic protein-positive astrocytes and the expression levels of all 7 astrocytic receptors and channels in HS lesions were significantly increased. We previously described unique astrogliosis in epileptic lesions similar to what was observed in this study. This phenomenon is considered to trigger activation of the related signaling pathways and then contribute to epileptogenesis. Thus, astrocytes in epileptic lesion may show self-hyperexcitability and contribute to epileptogenesis through the endogenous astrocytic receptors and channels. These findings may suggest novel astrocytic receptor-related targets for the pharmacological treatment of epilepsy.

Sections du résumé

BACKGROUND BACKGROUND
Hippocampal sclerosis (HS) is one of the major causes of intractable epilepsy. Astrogliosis in epileptic brain is a peculiar condition showing epileptogenesis and is thought to be different from the other pathological conditions. The aim of this study is to investigate the altered expression of astrocytic receptors, which contribute to neurotransmission in the synapse, and channels in HS lesions.
METHODS METHODS
We performed immunohistochemical and immunoblotting analyses of the P2RY1, P2RY2, P2RY4, Kir4.1, Kv4.2, mGluR1, and mGluR5 receptors and channels with the brain samples of 20 HS patients and 4 controls and evaluated the ratio of immunopositive cells and those expression levels.
RESULTS RESULTS
The ratio of each immunopositive cell per glial fibrillary acidic protein-positive astrocytes and the expression levels of all 7 astrocytic receptors and channels in HS lesions were significantly increased. We previously described unique astrogliosis in epileptic lesions similar to what was observed in this study.
CONCLUSION CONCLUSIONS
This phenomenon is considered to trigger activation of the related signaling pathways and then contribute to epileptogenesis. Thus, astrocytes in epileptic lesion may show self-hyperexcitability and contribute to epileptogenesis through the endogenous astrocytic receptors and channels. These findings may suggest novel astrocytic receptor-related targets for the pharmacological treatment of epilepsy.

Identifiants

pubmed: 31166880
doi: 10.1177/1093526619855488
doi:

Substances chimiques

Biomarkers 0
Potassium Channels 0
Receptors, Metabotropic Glutamate 0
Receptors, Purinergic P2Y 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

532-539

Auteurs

Yoshinori Aoki (Y)

Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.
Department of Pediatrics, The University of Tokyo, Tokyo, Japan.

Sae Hanai (S)

Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.

Sayuri Sukigara (S)

Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.

Taisuke Otsuki (T)

Epilepsy Center, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Takashi Saito (T)

Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.
Epilepsy Center, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Eiji Nakagawa (E)

Epilepsy Center, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Takanobu Kaido (T)

Epilepsy Center, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Yuu Kaneko (Y)

Epilepsy Center, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Akio Takahashi (A)

Epilepsy Center, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Naoki Ikegaya (N)

Epilepsy Center, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Masaki Iwasaki (M)

Epilepsy Center, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Kenji Sugai (K)

Epilepsy Center, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Masayuki Sasaki (M)

Epilepsy Center, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Yuichi Goto (Y)

Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.
Epilepsy Center, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Akira Oka (A)

Department of Pediatrics, The University of Tokyo, Tokyo, Japan.

Masayuki Itoh (M)

Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan.
Epilepsy Center, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH